Randomization before or after sample analysis [General Sta­tis­tics]

posted by Tushar.g  – India, 2014-05-06 15:41 (4435 d 17:21 ago) – Posting: # 12918
Views: 4,251

Hi Ken,

Discarding subjects to make design balanced is not right, you would lose valuable information. It is Neither good idea nor any regulatory allow you to do so.
As Detlew said, SAS’s PROC GLM as well as WinNonlin will take care of calculation of unbalanced designs. Don’t worry.

❝ Which is the right approach ? :confused:


I would say, It will be cumbersome to justify the exclusion of subjects from regulatory point of view.


Regards,
Tushar

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
379 visitors (0 registered, 379 guests [including 22 identified bots]).
Forum time: 09:03 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5